MRTN(MRTN)
MRTN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $892M | $959M |
| Low | $888M | $954M |
| High | $896M | $963M |
| EBITDA Avg | $153M | $164M |
| Low | $152M | $164M |
| High | $154M | $165M |
| EBIT Avg | $58M | $62M |
| Low | $58M | $62M |
| High | $58M | $63M |
| Net Income Avg | $24M | $46M |
| Low | $24M | $46M |
| High | $25M | $47M |
| EPS Avg | $0.30 | $0.57 |
| Low | $0.30 | $0.57 |
| High | $0.30 | $0.57 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $230M | $233M | $221M | $239M | $247M | $252M |
| Low | $227M | $230M | $219M | $236M | $244M | $250M |
| High | $232M | $235M | $223M | $242M | $249M | $255M |
| EBITDA Avg | $39M | $40M | $38M | $41M | $42M | $43M |
| Low | $39M | $39M | $37M | $41M | $42M | $43M |
| High | $40M | $40M | $38M | $41M | $43M | $44M |
| EBIT Avg | $15M | $15M | $14M | $16M | $16M | $16M |
| Low | $15M | $15M | $14M | $15M | $16M | $16M |
| High | $15M | $15M | $15M | $16M | $16M | $17M |
| Net Income Avg | $8M | $9M | $7M | $12M | $13M | $15M |
| Low | $8M | $8M | $6M | $12M | $12M | $14M |
| High | $8M | $9M | $7M | $12M | $13M | $15M |
| EPS Avg | $0.10 | $0.10 | $0.08 | $0.15 | $0.15 | $0.18 |
| Low | $0.09 | $0.10 | $0.08 | $0.15 | $0.15 | $0.18 |
| High | $0.10 | $0.11 | $0.08 | $0.15 | $0.16 | $0.18 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |